Fritsch Lab

Our group aims to advance precision treatment for gastrointestinal and hepatobiliary cancers. Our research is translational, operating between bench and bedside. We aim to address clinically relevant questions of oncogene targeting in GI Cancers, employing molecular profiling techniques and patient-derived organoid modeling. Moreover, we develop and employ molecular monitoring technologies, aiming to personalize cancer treatment based on individual treatment responses.